BK
Bhavesh Kiritkumar Bhagat
About Bhavesh Kiritkumar Bhagat
Data last updated:
Bhavesh Kiritkumar Bhagat is a Director at Sgpharma Private Limited (since 2004) and Director at Sgpharma Global Private Limited (since 2020). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹22.49 Cr; the largest is Sgpharma Private Limited at ₹21.85 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 May 2004 | 2004 | ₹21.85 Cr (FY 2025) | Active | |
| Director | 17 Nov 2020 | 2020 | ₹64.3 Lakh (FY 2025) | Active |
Board colleagues of Bhavesh Kiritkumar Bhagat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chetan Kiritkumar Bhagat | 00023284 | Sgpharma Private Limited , Sgpharma Global Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavesh Kiritkumar Bhagat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavesh Kiritkumar Bhagat
Bhavesh Kiritkumar Bhagat currently holds 2 directorships: Sgpharma Private Limited (Director, since 17 May 2004, revenue ₹21.85 Cr (FY 2025)); Sgpharma Global Private Limited (Director, since 17 Nov 2020, revenue ₹64.3 Lakh (FY 2025)).
Bhavesh Kiritkumar Bhagat was first appointed on 17 May 2004 as Director at Sgpharma Private Limited. The most recent appointment on record is 17 Nov 2020 at Sgpharma Global Private Limited.
The 2 current companies of Bhavesh Kiritkumar Bhagat that report revenue have a combined latest revenue of ₹22.49 Cr: Sgpharma Private Limited ₹21.85 Cr (FY 2025); Sgpharma Global Private Limited ₹64.3 Lakh (FY 2025).
The current boards of Bhavesh Kiritkumar Bhagat's companies include Chetan Kiritkumar Bhagat (Sgpharma Private Limited).